Menu

All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: NEW CE REQUIREMENTS! More Information

Featured Activity

This home-study activity describes the impact of hyperglycemia in the critical care setting, as well as research on the development of clinical targets for optimal glycemic control.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

SHOW SEARCH

Better Glycemic Control: How Sweet It Is!

Activity Downloads

Activity

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.

Activity Description

This educational activity will describe the impact of hyperglycemia in the critical care setting, as well as research on the development of clinical targets for optimal glycemic control. The author, Cathy Moore, will discuss appropriate management of hyperglycemia in critically ill patients, including current authoritative recommendations. She will also describe the benefits of electronic software programs that support individualized dosing protocols and have become the gold standard for insulin infusion management.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Identify 3 complications associated with hyperglycemia in the critical care patient
  • Discuss current clinical guidelines for targeted blood glucose levels
  • Compare current strategies for insulin infusion management

Faculty

Cathy M. Moore, MSN, RN, NEA-BC Director, Critical Care Services
Gaston Memorial Hospital
Gastonia, North Carolina

Disclosure

It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational activity. Cathy Moore reports serving as a speaker and/or consultant for Hospira, Inc.

Please note: The opinions expressed in this activity should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.

CE Accreditation

Release Date: 09-15-2011
Expiration Date: 09-15-2014

Nurses

Nursing credit is provided for this home-study activity through collaboration between ProCE, Inc. and Wild Iris Medical Education, Inc., a provider of continuing education accredited by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 1.0 contact hour of nurse CE credit.

Funding

This activity is supported by an educational grant from Hospira, Inc.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.